Speakers
| Rena Conti | Boston University Institute for Health System Innovation and Policy, Associate Research Director of Biopharma and Public Policy |
| R. John Glasspool | MIT Center for Biomedical Innovation: NEWDIGS, Financing and Reimbursement of Cures in the US (FoCUS) Project, Senior Advisor; Anthos Therapeutics, CEO |
| Joanne Kurtzberg | Duke University School of Medicine, Director of the Marcus Center for Cellular Cures (MC3) |
| Gillian Woollett | Avalere Health, Principal Research Scientist |
Experts and Analysts
| Peter Bach | Memorial Sloan Kettering Cancer Center, Director of the Center for Health Policy and Outcomes |
| Thomas Barker | Foley Hoag, LLP, Partner and Co-Chair of Healthcare Practice |
| Justin Bekelman | Penn Center for Cancer Care Innovation at the Abramson Cancer Center, Director; University of Pennsylvania Perelman School of Medicine, Associate Professor |
| Robert W. Dubois | National Pharmaceutical Council, Chief Science Officer & Executive Vice President |
| Lisa Bo Feng | Cystic Fibrosis Foundation, Senior Director of Policy and Advocacy |
| Jennifer Bright | Momentum Health Strategies, Executive Director of Innovation and Value Initiative |
| Sarah Emond | Institute for Clinical and Economic Review, Executive Vice President and Chief Operating Officer |
| Andrew Hu | Patient-Centered Outcomes Research Institute, Director of Policy and Government Relations |
| Karen Katz | MIT Center for Biomedical Innovation: NEWDIGS, Financing and Reimbursement of Cures in the US (FoCUS) Project, Director |
| Eleanor M. Perfetto | National Health Council, Executive Vice President of Strategic Initiatives |
| Morgan Romine | Duke Margolis Center for Health Policy, Policy Fellow for Strategic Engagement |
| Jeremy Sharp | Waxman Strategies, Senior Vice President |
| Zachary Zalewski | Avalere Health, Consultant |
Government
| Anna Abram | FDA, Deputy Commissioner for Policy, Planning, Legislation and Analysis |
| John Coster | CMS, Director of Division of Pharmacy at Center for Medicaid and Chip Services |
| Molly Morein | Medicare Payment Advisory Commission, Special Assistant |
| Matt Salo | National Association of Medicaid Directors, Executive Director |
| Anne Schwartz | Medicaid and CHIP Payment and Access Commission, Executive Director |
| Elad Sharon | National Institutes of Health, Senior Investigator in the Investigational Drug Branch of the National Cancer Institute |
Stakeholders
| Jeremy Allen | Spark Therapeutics, Inc., Head of Government Affairs |
| Holly Campbell | Pharmaceutical Research and Manufacturers of America, Deputy Vice President of Public Affairs |
| Erin Darling | Merck, Associate Vice President of Federal Policy and Government Relations |
| Shari Erickson | American College of Physicians, Vice President of Government Affairs |
| Betsy Foss-Campbell | American Society of Gene and Cell Therapy, Director of Policy and Advocacy |
| Janet Lambert | Alliance for Regenerative Medicine, CEO |
| Lisa Mostovoy | Blue Cross Blue Shield Association, Executive Director of Clinical Pharmacy Services |
| Murray Ross | Kaiser Permanente, Government Relations & Institute for Health Policy |
| Heidi Rosvold-Brenholtz | Healthy Women, Senior Vice President for Strategic Engagement of Policy and Science |
| Mark Skinner | Institute for Policy Advancement Ltd., President & CEO; Former Head of the National Hemophilia Foundation |
| Gretchen C. Wartman | National Minority Quality Forum, Vice President for Policy and Program |
| Steven Wojcik | National Business Group on Health, Vice President of Public Policy |